drugset

drugset / Trial / NCT02403401

Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women

NCT02403401 ↗

Phase 3 Completed 1471 enrolled Bayer

NaSingle-groupOpen-labelPrevention

Summary

Purpose of the study is to investigate safety and contraceptive efficacy of an LNG-containing intravaginal ring.

Timeline

Start: 2015-05-15
Primary completion: 2016-07-07
Completion: 2016-07-07

Publications

Nave R, Hochel J, Mellinger U, Kohnke A, Elliesen J, Schmitz H. Pearl Index study with levonorgestrel-releasing intravaginal rings: using pharmacokinetic results to investigate treatment compliance as a potential contributor for contraceptive failure. Hum Reprod. 2020 Nov 1;35(11):2515-2523. doi: 10.1093/humrep/deaa195.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Levonorgestrel	Small molecule	40 ug	Other

Indications

No indication recorded.